Literature DB >> 17542462

Advancing integration of HIV, STD, and viral hepatitis services: state perspectives.

Peter Whiticar1, Thomas Liberti.   

Abstract

Entities:  

Mesh:

Year:  2007        PMID: 17542462      PMCID: PMC1831804          DOI: 10.1177/00333549071220S218

Source DB:  PubMed          Journal:  Public Health Rep        ISSN: 0033-3549            Impact factor:   2.792


× No keyword cloud information.
  17 in total

1.  Providing hepatitis B vaccination to injection drug users: referral to health clinics vs on-site vaccination at a syringe exchange program.

Authors:  D C Des Jarlais; D G Fisher; J C Newman; B N Trubatch; M Yancovitz; D Paone; D Perlman
Journal:  Am J Public Health       Date:  2001-11       Impact factor: 9.308

2.  The Massachusetts HIV, hepatitis, addiction services integration (HHASI) experience: responding to the comprehensive needs of individuals with co-occurring risks and conditions.

Authors:  Heidi L Hoffman; Carolyn A Castro-Donlan; Victoria M Johnson; Daniel R Church
Journal:  Public Health Rep       Date:  2004 Jan-Feb       Impact factor: 2.792

3.  The Program Evaluation and Monitoring System: a key source of data for monitoring evidence-based HIV prevention program processes and outcomes.

Authors:  Craig W Thomas; Bryce D Smith; Linda Wright-DeAgüero
Journal:  AIDS Educ Prev       Date:  2006-08

4.  CDC and progress toward integration of HIV, STD, and viral hepatitis prevention.

Authors:  John W Ward; Kevin A Fenton
Journal:  Public Health Rep       Date:  2007       Impact factor: 2.792

Review 5.  Self-report among injecting drug users: a review.

Authors:  S Darke
Journal:  Drug Alcohol Depend       Date:  1998-08-01       Impact factor: 4.492

6.  Acceptance and completion of hepatitis B vaccination among drug users in New York City.

Authors:  D C Ompad; S Galea; Y Wu; C M Fuller; M Latka; B Koblin; D Vlahov
Journal:  Commun Dis Public Health       Date:  2004-12

7.  Sexually transmitted diseases treatment guidelines, 2006.

Authors:  Kimberly A Workowski; Stuart M Berman
Journal:  MMWR Recomm Rep       Date:  2006-08-04

8.  A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults.

Authors:  Eric E Mast; Cindy M Weinbaum; Anthony E Fiore; Miriam J Alter; Beth P Bell; Lyn Finelli; Lance E Rodewald; John M Douglas; Robert S Janssen; John W Ward
Journal:  MMWR Recomm Rep       Date:  2006-12-08

9.  Integrating viral hepatitis prevention services into an urban STD clinic: Denver, Colorado.

Authors:  Julie Subiadur; Jennie L Harris; Cornelis A Rietmeijer
Journal:  Public Health Rep       Date:  2007       Impact factor: 2.792

10.  Texas statewide hepatitis C counseling and testing, 2000-2005.

Authors:  Gary Heseltine; Jenny McFarlane
Journal:  Public Health Rep       Date:  2007       Impact factor: 2.792

View more
  5 in total

1.  Integrating viral hepatitis prevention into public health programs serving people at high risk for infection: good public health.

Authors:  Joanna Buffington; T Stephen Jones
Journal:  Public Health Rep       Date:  2007       Impact factor: 2.792

2.  CDC and progress toward integration of HIV, STD, and viral hepatitis prevention.

Authors:  John W Ward; Kevin A Fenton
Journal:  Public Health Rep       Date:  2007       Impact factor: 2.792

3.  Program collaboration and service integration activities among HIV programs in 59 U.S. health departments.

Authors:  Lauren F Fitz Harris; Lauren Toledo; Erica Dunbar; Gustavo A Aquino; Steven R Nesheim
Journal:  Public Health Rep       Date:  2014 Jan-Feb       Impact factor: 2.792

4.  Prevalence of Chlamydia trachomatis infection in women, heterosexual men and MSM visiting HIV counselling institutions in North Rhine-Westphalia, Germany - should Chlamydia testing be scaled up?

Authors:  Anne Lallemand; Viviane Bremer; Klaus Jansen; Stine Nielsen; Dieter Münstermann; Andreas Lucht; Carsten Tiemann
Journal:  BMC Infect Dis       Date:  2016-10-26       Impact factor: 3.090

5.  Developing target product profiles for Neisseria gonorrhoeae diagnostics in the context of antimicrobial resistance: An expert consensus.

Authors:  Cecilia Ferreyra; Jennifer Osborn; Francis Moussy; Emilie Alirol; Monica Lahra; David Whiley; William Shafer; Magnus Unemo; Jeffrey Klausner; Cassandra Kelly Cirino; Teodora Wi
Journal:  PLoS One       Date:  2020-09-01       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.